Key result
Treatment of atypical hypoadrenocorticism with glucocorticoid supplementation and discontinuation of IV fluids led to the resolution of a secondary dilated cardiomyopathy phenotype in a dog.
Why the study?
Development of a dilated cardiomyopathy phenotype has not been described in dogs as a sequela of untreated hypoadrenocorticism.
Does glucocorticoid supplementation and fluid management resolve dilated cardiomyopathy phenotype in a dog with atypical hypoadrenocorticism?
Case Report (n=1)
Does glucocorticoid supplementation and fluid management resolve dilated cardiomyopathy phenotype in a dog with atypical hypoadrenocorticism?
Atypical hypoadrenocorticism in dogs may present with a reversible dilated cardiomyopathy phenotype that can be exacerbated by standard aggressive fluid resuscitation.
Answers are grounded in this paper and cite their sources.
Single case links atypical hypoadrenocorticism to reversible DCM phenotype in a grain-free-fed dog; leaves open causality and need for prospective confirmation.
OBJECTIVE: To report the possible occurrence of dilated cardiomyopathy phenotype associated with atypical hypoadrenocorticism and subsequent marked improvement with treatment in a mixed breed dog. CASE SUMMARY: A 4.5-year-old, neutered male mixed breed dog was evaluated for a history and clinicopathological changes consistent with atypical hypoadrenocorticism. The dog was being fed a grain-free diet. While hospitalized for supportive care and diagnostics, the patient developed and was diagnosed with biventricular congestive heart failure secondary to dilated cardiomyopathy phenotype and IV fluid administration. The left-sided congestive heart failure resolved with discontinuation of IV fluid therapy and short-term administration of diuretics. After treatment of atypical hypoadrenocorticism with glucocorticoid supplementation, and while continuing to be fed varying grain-free diets, the patient's dilated cardiomyopathy phenotype largely resolved. The patient fully recovered and did not require any long-term cardiac medications. NEW OR UNIQUE INFORMATION PROVIDED: Development of dilated cardiomyopathy phenotype has not been described in dogs as a sequela of untreated hypoadrenocorticism but has been reported in human literature. Given the fact that standard management of hypoadrenocorticism typically involves aggressive fluid resuscitation, awareness of this potential sequela is important for patients that fail to respond or develop signs consistent with volume overload.
No takes yet. Share an insight, caveat, or question.
Riggs et al. (2023) conducted a case report in Atypical hypoadrenocorticism and dilated cardiomyopathy phenotype (n=1). Glucocorticoid supplementation and discontinuation of IV fluid therapy was evaluated on Resolution of dilated cardiomyopathy phenotype. Treatment of atypical hypoadrenocorticism with glucocorticoid supplementation and discontinuation of IV fluids led to the resolution of a secondary dilated cardiomyopathy phenotype in a dog.
Synapse has enriched 10 related papers. Consider them for comparative context: